Free Trial
CVE:BRM

BioRem (BRM) Stock Price, News & Analysis

BioRem logo
C$1.88 -0.12 (-6.00%)
As of 05/28/2025 03:59 PM Eastern

About BioRem Stock (CVE:BRM)

Key Stats

Today's Range
C$1.67
C$1.99
50-Day Range
C$1.76
C$2.50
52-Week Range
C$1.67
C$3.45
Volume
250,112 shs
Average Volume
51,624 shs
Market Capitalization
C$30.83 million
P/E Ratio
5.81
Dividend Yield
6.47%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.

Receive BRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter.

BRM Stock News Headlines

BRM:CA BioRem Inc.
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
BRM:CA Stock Price
BioRem Inc. (BRM.V)
See More Headlines

BRM Stock Analysis - Frequently Asked Questions

BioRem's stock was trading at C$3.05 at the beginning of 2025. Since then, BRM shares have decreased by 38.4% and is now trading at C$1.88.
View the best growth stocks for 2025 here
.

BioRem Inc. (CVE:BRM) released its quarterly earnings data on Wednesday, November, 6th. The company reported $0.12 EPS for the quarter. BioRem had a net margin of 12.91% and a trailing twelve-month return on equity of 65.14%.

Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and K92 Mining Inc. (KNT.V) (KNT).

Company Calendar

Last Earnings
11/06/2024
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Pollution & Treatment Controls
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:BRM
CIK
N/A
Fax
N/A
Employees
34,300
Year Founded
N/A

Profitability

Trailing P/E Ratio
5.81
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$5.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$41.84 million
Cash Flow
C$0.51 per share
Price / Cash Flow
3.70
Book Value
C$0.63 per share
Price / Book
2.98

Miscellaneous

Free Float
N/A
Market Cap
C$30.83 million
Optionable
Not Optionable
Beta
0.85
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:BRM) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners